From the ∗Alshifaa Hospital, Nineveh Health Directorate

†Department of Pharmacognosy and Medicinal Plants

‡Department of Pharmaceutical Chemistry

§Department of Pharmacology and Toxicology

∥Department of Pharmaceutics

¶University of Mosul, College of Pharmacy, Mosul, Iraq

∗∗College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq.

Correspondence to: Mohammed N. Abed, PhD, University of Mosul, College of Pharmacy, Department of Pharmaceutical Chemistry, University street, Mosul, Nineveh province, 41002, Iraq. E-mail: [email protected].

The authors have no funding or conflicts of interest to disclose.

F.A., M.A., and M.J. developed the trial design. M.A. was responsible for the organization and coordination of the trial. M.Q., F.A., M.A., M.J., and M.A. conducted the data analysis. M.A. conceived and led the project. All authors contributed equally to the drafting and approval of the final version.